Scientists

Scientists

For science to make the news in a rigorous and attractive way, good sources are needed. Because access to scientific knowledge is a citizen's right.

¿Qué me ofrece?

Help science make headlines with rigour and context. We’ll ask you for feedback on current events in your field and you can participate in the briefings we’ll organise. Need to prepare for an interview? Use our resources on science communication.

Icono
Cómo trabajamos

We’re on the lookout for controversial information about science and we will contact you for your analysis in your area. Do you want to be part of our sources? Contact us. We will not pass your contact details on to anyone else. You can find out more about how we work here.   

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Ketamine in pill form is effective and safe against depression resistant to other treatments

Ketamine extended-release tablets are effective, safe and well tolerated in patients with depression resistant to other treatments, according to a phase 2 clinical trial. Compared to intranasal or intravenous use of ketamine, these oral tablets are easier to administer and would provide less dissociative intensity, lower risk of abuse and cardiovascular adverse effects, the authors write in Nature Medicine. 

0

New genetic predisposition to obesity linked to a blood group described

About one in 5,000 people have a genetic variant in the SMIM1 gene that results in a particular type of blood type called Vel negative. An international team of researchers now describes the same variant as being associated with a predisposition to obesity, metabolic disturbances and lower resting energy expenditure. Women studied with the variant weigh, on average, 4.6 kg more, while in men the difference is about 2.4 kg. The results are published in the journal Med, published by the Cell group. 

0

Advocates call for earlier screening for gestational diabetes

Management of gestational diabetes should include earlier testing during pregnancy, as well as testing in the postpartum period, according to a series of papers published in The Lancet. Screening is usually done during the second half of pregnancy, but the authors note that diagnosis and treatment is especially beneficial before 14 weeks of pregnancy. 

0

Carbon stored in plants more ephemeral than previously thought

Carbon stored globally by plants is shorter-lived and more vulnerable to climate change than previously thought, according to a study published in Science. This has implications for nature's role in climate change mitigation, including the potential for carbon removal projects such as mass tree planting. The research reveals that existing climate models underestimate the amount of carbon dioxide (CO2) that vegetation absorbs globally each year, but overestimate how long that carbon stays there. 

0

Two clinical trials test immunomodulator to improve cancer immunotherapy

Cancer immunotherapy, and in particular the so-called checkpoint inhibitors, have improved the prognosis of several types of tumours. However, they are not effective in everyone. Two early-stage clinical trials have tested the addition of a type of immunomodulator to this therapy in patients with lung cancer and Hodgkin's lymphoma, with apparent good results. The results are published in the journal Science.  

0

Mosquito-borne diseases: an increasing risk in Spain

International health organisations are warning about the spread in Europe of mosquito species that transmit diseases such as dengue fever. In Spain, where they are already widespread across much of the country, the Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES) warns of the risk of West Nile virus, and says that the summer is expected to be complicated. In this guide, we bring together information to understand this public health issue. 

0

A single copy of a protective gene variant helps delay early Alzheimer's disease

A family of more than 1,000 members with origins in Colombia has a mutation called "paisa" that leads to the development of Alzheimer's disease. In 2019, an added mutation in the apoE gene called "Christchurch" was described as conferring strong protection to an individual carrying two copies of it. Now, a study has found that 27 family members carry a single copy and that it is also associated with some degree of protection. According to the authors, who publish their findings in the journal NEJM, the discovery could be used to develop new treatments for the disease. 

0

Study compares safety of autonomous vehicles versus human-driven vehicles

A study has compared data from 2,100 accidents involving autonomous vehicles and just over 35,000 accidents involving human-driven vehicles between 2016 and 2022, mainly in California (US). Their findings are that autonomous vehicles are safer in many driving situations, but suffer more accidents in situations such as turning times or during dawn and dusk. The results are published in the journal Nature Communications.  

0